Aerosolized Burkholderia pseudomallei, the causative agent of melioidosis, can infect many species of mammals (including humans), causing rapid, severe pneumonia with high mortality. Diagnosis in humans is challenging, as few organisms can be detected in blood or other noninvasive samples. Although it cannot be said that the model is established, studies to date indicate that rhesus macaques may represent a good model of human melioidosis. This is supported by the results of this study. The early progression of meliodosis in the rhesus macaque was studied in an effort to better understand the disease and the application of rapid diagnostic methods. Results indicate that a PCR analysis of key diagnostic samples such as nasal swabs, throat swabs, tracheo bronchial lymph node aspirates and broncho-alveolar lavage may be a useful component of a rapid diagnostic algorithm in case of aerosol exposure.
INTRODUCTION
Burkholderia pseudomallei, a Gram-negative, motile, nonspore-forming bacillus, causes melioidosis. The organism infects many species of mammals and can survive and replicate to some extent in the soil (Vetri & DeShazer, 2007) . The persistence of this organism in the environment results in an agriculturally associated occupational hazard (Sprague & Neubauer, 2004; Vetri & DeShazer, 2007) . The most common route of infection in natural exposure remains unclear; however, it is apparent that infection can occur by aerosol and probably also occurs orally, as well as through breaks in the skin (Dance, 2002; Limmathurotsakul et al., 2013) . Aerosolization due to monsoon rainfall has been associated with severe infections in humans with a short incubation period of 1-21 days before the onset of pneumonia and/or septicaemia (Currie et al., 2000; Saravu et al., 2008) . The low infective dose by this route and potential for rapid, severe and frequently fatal pneumonia makes B. pseudomallei a biothreat that demands particular attention in terms of refinement of rapid diagnostic strategies to provide for treatment of patients and support for epidemiological efforts (Vetri & DeShazer, 2007) . Diagnosis of naturally occurring disease is difficult because the organism is found only in extremely low concentrations in blood (Chantratita et al., 2007; Fritz et al., 1986; Huis in't Veld et al., 2005) .
Melioidosis has been extensively studied in rodent models; however, the applicability of models other than nonhuman primates (NHPs) for diagnostic development for use in humans is uncertain (Jeddeloh et al., 2003; Sprague & Neubauer, 2004; Titball et al., 2008; van Schaik et al., 2008) . NHPs vary greatly in response to exposure, yet present a pattern of disease similar to that seen in humans. Miller et al. (1948) described spontaneously resolving abscessation in rhesus macaques, but either due to the inoculation route, individual variability or the strain used incorrectly concluded that rhesus macaques were only slightly susceptible to B. pseudomallei. Kaufmann et al. (1970) described several cases of naturally occurring meliodosis in macaques and one in a chimpanzee, clearly illustrating the pathogenic potential of the organism for NHPs. These case histories showed the potential for dissemination to other organs and non-resolving abscessation in some animals, while at the same time strongly indicating that many animals may be infected, seroconvert and recover spontaneously. Fritz et al. (1986) provided a case report that illustrates the tendency in rhesus macaques, similar to humans, for melioidosis to be latent for long periods and recrudesce, resulting in severe morbidity or death. Dance et al. (1992) described a major outbreak in macaques that represents a valuable baseline for comparison not only with human disease, but also for experimentally induced disease in NHPs. Nelson et al. (2011) have reported a thorough study of pathogenesis of B. pseudomallei in marmosets. The extremely short time period from infection to a moribund state and relatively high bacteraemias in the marmoset model are not consistent with human disease. Yeager et al. (2012) have reported a comparative study of disease history in rhesus and African Green Monkeys, concluding that African Green Monkeys may be a better model for countermeasure development.
The study reported here is an effort to build on the initial modelling efforts noted above, to develop the NHP model by studying the disease history of early, acute aerosol-exposure melioidosis, with the specific goal of shedding light on possible enhanced diagnostic algorithms. This study was not intended to statistically assess or compare assay performance; however, initial indication of the suitability of some assays may be derived. In addition to initial assessment of selected currently available diagnostics, one outcome of this study is the establishment of an archive of tissues and other biological samples that may be suitable for further diagnostic development without additional animal use.
METHODS
B. pseudomallei strain and culture for aerosol exposure. B. pseudomallei strain 1026b was cultured on Difco tryptone agar with 4 % glycerol, 15 mg polymyxin B ml 21 and 32 mg ampicillin ml 21 for 18 h (Amemiya et al., 2002) .
Experimental animals. The US Army Medical Research Institute for Infectious Disease (USAMRIID) is fully Association for Assessment and Accreditation of Laboratory Animal Care International accredited. Research at USAMRIID is conducted in compliance with the USA Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals, and adheres to principles stated in the guide produced by the National Research Council (2010). Animal care was provided in accordance with these established guidelines.
For this individual study, 12 adult rhesus macaques (Macaca mulatta) were surgically implanted with TA-D70 temperature and activity telemetry transmitters, while an additional 12 macaques had been implanted previously (Data Sciences International). These latter 12 animals represent 'historical controls' from a previous study in which all handling, conditions and time points were identical to this study. Experimental animals were exposed to aerosolized B. pseudomallei organisms diluted in normal saline solution, whereas historical controls were exposed to saline solution only. Temperature and activity data were sampled every 15 min from 1 week before exposure until the time of euthanasia. Complete blood counts (CBC) and blood chemistries were performed 14 and 30 days before exposure in order to provide a baseline for comparison with samples taken at the time of euthanasia. Swab samples were taken from the pharynx and nares, and broncho-alveolar lavage (BAL) was performed immediately before exposure in order to obtain animal-matched negative control samples for PCR analysis.
Aerosol exposure. Experimental animals were exposed to approximately 1 mm mass median aerodynamic diameter, aerosolized particles of B. pseudomallei in a manner that standardized the number of c.f.u. inhaled. Animals were anaesthetized with 9 mg ketamine kg 21 and 0.1 mg acepromazine kg 21 intramuscularly, and respiratory minute volumes were estimated immediately before exposure using head-out plethysmography (Buxco Research Systems). Respiratory minute volume was assumed to be constant over the exposure period. Each animal was exposed separately in a well-characterized dynamic airflow exposure chamber (Dabisch et al., 2010) . Small-particle aerosols were generated using 10 ml agent diluted in normal saline in a 3-jet Collison nebulizer (BGI). The generated aerosol was sampled using all-glass impingers attached to the exposure chamber. The contents of the impinger were assayed post-exposure to estimate the mean agent concentration in the chamber during the exposure. The estimated inhaled dose was calculated as the product of the chamber aerosol concentration, the respiratory minute volume and exposure duration. To achieve a targeted dose, the exposure duration was varied from animal to animal as both the chamber aerosol concentration and estimated respiratory minute volume were assumed to be constant throughout the exposure period. Exposure durations ranged from 5 to 15 min. The aerosol respiratory deposition fraction was assumed to be 100 %. After aerosol exposure, the head of each animal was wiped with a soap solution to remove deposited aerosol, and animals were housed individually under biosafety level 3 conditions. Necropsy and tissue collection. Three animals from each group (i.e. experimental or historical control) were euthanized on day postexposure (DPE) 1, 3, 5 and 7. On the day of euthanasia, CBC and blood chemistries, swab sampling (pharynx and nares) and BAL were performed. Post-mortem examination and tissue collection was performed on all animals in a biosafety level 3 necropsy suite. During necropsy, all organs and tissues were examined grossly. Representative samples of lung, liver and spleen were collected for bacterial culture with aseptic technique prior to taking a complete set of tissues for histology and other diagnostic evaluations. Approximately 1 g tissue samples taken for bacterial culture were placed in sterile cryovials and processed immediately after necropsy.
Tissue samples collected for histology and other diagnostic evaluation consisted of: tongue, tonsil, salivary gland, nares, lip, larynx, trachea, oesophagus, thyroid gland, parathyroid gland, aorta, thymus, gallbladder, urinary bladder, pituitary gland, adrenal glands, axillary lymph node, inguinal lymph node, stomach, pylorus, duodenum, pancreas, jejunum, ileum, caecum, colon, haired skin, mammary gland, skeletal muscle, sciatic nerve, brachial plexus, eyes, mandibular lymph node, liver, gallbladder, kidneys, spleen, heart, lungs, tracheobronchial lymph node, mesenteric lymph node, reproductive organs, ileocecal junction, large intestine, bone marrow and brain. Tissue samples were immersion fixed in 10 % neutral-buffered formalin for 21 days and prepared for histopathology. Sections were embedded in paraffin, sectioned and cut at 5-6 mm, mounted on glass slides, and then stained with haematoxylin and eosin in preparation for examination by light microscopy.
Immunohistochemistry. Unstained tissue sections were deparaffinized, rehydrated, subjected to methanol hydrogen peroxide block for 30 min then rinsed in PBS. A serum-free protein block plus 5 % normal goat serum was applied for 30 min. A mouse mAb against B. pseudomallei was diluted 1 : 1200 and incubated at room temperature for 60 min (B. pseudomallei 3B3-5 mouse mAb courtesy of Dr Sylvia Travino, USAMRIID). A polymer-labelled horseradish peroxidase
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anti-rabbit secondary antibody was applied for 30 min at room temperature (EnVision Plus system; DAKO). All sections were exposed to 3, 39-diaminobenzidine (DAB) for approximately 5 min, rinsed, counter-stained with haematoxylin, dehydrated and coverslipped with Permount. The same tissues from animals infected with anthrax, Klebsiella pneumoniae and monkey pox were also tested to rule out any non-specific reactions, and none showed immunoreactivity. These tissues were derived from a set of tissues with known immunoreactivity to the various agents, specially archived at USAMRIID for the purpose of immunohistochemistry assay development.
Bacterial culture of tissues, fluids and swabs. For bacterial culture, tissues were processed using a manual tissue grinder at a 10 % concentration (w/v) in PBS. Swabs were immersed in 1 ml PBS for approximately 10 min and then vortexed. EDTA anti-coagulated blood, serum and BAL wash fluid were used without further manipulation. A neat, 100 ml sample was plated and subsequently, all samples were serially diluted (ten-fold) up to five dilutions. Volumes of 10 ml of serial dilutions were cultured on Difco tryptone agar with 4 % glycerol, 15 mg polymyxin B ml 21 and 32 mg ampicillin ml 21 and incubated at 37 uC in a humid incubator overnight. This technique of blood culture was not designed to replicate clinical blood culture techniques using bottles and, as performed, may have substantially lower sensitivity. As the first plated dilution was neat, whole blood, or other undiluted fluid, the theoretical limit of detection would be one organism per 100 ml, or 10 c.f.u. ml 21 . Culture samples were evaluated for colonies demonstrating phenotypic characteristics of B. pseudomallei.
PCR. Swab diluents, BAL wash fluid, tissue samples, blood (undiluted) and serum (undiluted) were extracted using the Qiagen DNA blood kit according to the manufacturer's instructions, using 140 ml samples. Amplification of nucleic acids (PCR) was performed using a Lightcycler 2.0 real-time PCR instrument (Roche Corp) with an assay specific for B. pseudomallei, as well as a more sensitive assay that detected both Burkholderia mallei and B. pseudomallei, i.e. a Burkholderia-genusspecific assay (detecting the IS407A insertion element) (see Table 1 ) (Nierman et al., 2004; Ulrich et al., 2006) . Assays were carried out in 20 ml volumes. Each assay contained 16 PCR buffer (50 mM Tris, pH 8.3; 250 mg BSA ml 21 ) (Hoffmann-La Roche), 0.2 mM dNTP mix, 1.0 U Platinum Taq DNA polymerase and 5 mM MgCl 2 (Invitrogen). Previously determined optimal concentrations of primers and probe were added, and 15 ml master mix was distributed to reaction tubes. Aliquots of 5 ml control/template/sample DNA were added just before analysis on the instrument. Thermal cycling conditions were standardized for both assays, and consisted of one cycle at 95 uC for 2 min, followed by 45 cycles of 95 uC for 5 s and 60 uC for 20 s. Fluorescence readings were taken at the end of each 60 uC step. Each reaction capillary tube was read in channel 1 (F1) with data analysed by the JBAIDS software. Samples were run in triplicate.
Statistical analysis. McNemar's exact test for symmetry was used to compare culture with the two PCR assays, as well as the two PCR assays to each other. Some comparisons result in no P value because the test cannot be performed on any contingency table with either an entirely empty row or column.
RESULTS
Estimated inhaled dosages (exposure dose) of B. pseudomallei averaged 59.1 c.f.u. (range 35-83.6) ( Table S1 available in JMM Online).
Clinical findings
All animals showed a clear disruption of the normal diurnal body temperature variation, beginning DPE 2. Individual animals showed substantial temperature variations, but the pattern of temperature disruption was remarkably consistent when compiled and evaluated in graphic form (Fig. 1) . Control animals maintained a normal diurnal rhythm (data not shown).
While clinical signs varied from time to time with individual animals, subjectively waxing and waning in severity with time, no animal that remained in the study beyond 3 days remained clinically normal throughout the observation period (see Tables S2 and S3 -clinically normal is defined as a total score of 5 on the assessment checklist; we also monitored food consumption). In terms of subjective clinical signs, animals were normal through DPE 2, but starting on DPE 3, activity started to be reduced as respiratory involvement increased (as indicated by increased respiratory rate and/or laboured and/or abdominal breathing). Clinical signs seemed to progressively worsen over time, e.g. worsening from reduced activity to dullness or depression, but remained predominantly limited to changes in activity and breathing. Unusual clinical signs included pica and ataxia (animal 1 on DPE 5-7). One of three animals remaining in the study at both DPE 5 and 7 became moribund and probably would have progressed to death.
CBC and blood chemistry results
In general, while there was wide biological variation seen in the challenged animals, a substantial change in WBC count Table 1 . Real-time PCR primer and probe sequences for 'BPISO'/'BMISO' (IS407A insertion element-Burkholderia-genus-specific screening assay) and 'BPSEC' (type III secretion system-B. pseudomallei-species-specific assay) was observed in most NHPs (Table S4) . CBCs were performed only on the day of euthanasia and, as such, were not in any way aligned with overt clinical illness as they would be for a human case, so these values cannot be compared with data from human cases for purposes of model validation; however, baseline samples were taken 14 and 30 days prior to euthanasia and were normal for experimental animals at those time points. On DPE 1, animal 11 showed severe neutropenia. On DPE 3, animal 8 showed mild neutrophilia and animal 9 had mild neutrophilia with increased lactate dehydrogenase (LDH) and alanine transaminase (ALT). On DPE 5, animals 4 and 6 had moderate neutrophilia, monocytosis and increased LDH, and animal 4 also had a mildly lowered red blood cell count, while animal 5 had severe neutropenia, mild monocytosis, increased LDH and blood urea nitrogen (BUN) and a decreased platelet count. On DPE 7, animals 1 and 3 had mildly low total white blood cell counts with relative monocytosis, animals 1 and 2 had a mildly reduced red blood cell count, and animal 2 also had a moderately reduced platelet count. Control animal results were either within USAMRIID reference ranges or consistent among three samples taken 14-16 days apart.
Culture and PCR results
Cultures were nearly always positive from lung tissue (92 %, 11/12), and always positive from BAL (100 %, 12/ 12) and enlarged tracheobronchial lymph nodes (100 %, 4/4). Other tissues were inconsistently positive and B. pseudomallei was only recovered from blood in two cases at DPE 5 (Table 2) . PCR results varied substantially from culture results in many cases (Table 3) . In lung tissue, PCR was not consistent with culture results on DPE 1 and 3, but was more consistent on DPE 5 and 7; i.e. PCR failed to detect organism in lung tissue on DPE 1 and 3, while culture was positive in all three animals on DPE 1, and two of three animals on DPE 3. However, PCR results from blood precisely matched culture results. In tissues, discordance between PCR and culture may have been due to non-uniform presence of bacteria within the tissue as PCR assays were not conducted on the same tissue sample as cultures. The expected higher proportion of positivity of the Burkholderia-genus-specific assay in comparison to the species-specific assay (as shown during assay development with purified B. pseudomallei DNA -see Table 1 ) was borne out in this study (Table 3) . A higher proportion of positivity was noted for the Burkholderia-genus-specific assay from all key samples including blood, serum (P.0.05), swab samples (P50.016), liver (P50.004) and spleen (P50.004). While the study was not powered to statistically assess or compare assay performance, it clearly cannot be said that PCR is more sensitive than culture, yet there was variation sample to sample in this comparison. Notably, tracheobronchial lymph nodes and BAL were always PCR positive on DPE 5 and 7 with both the more sensitive Burkholderia-genusspecific assay and the highly specific B. pseudomallei-speciesspecific assay. Of all 88 specimens analysed by both PCR and culture, 64 were positive for B. pseudomallei by culture (73 %), 56 were positive by the genus-specific PCR assay (64 %) and 22 were positive by the species-specific PCR assay (25 %) (see Tables 2 and S5 ).
Gross findings
A synopsis of pathological findings is given in Table 4 . The most common gross pathological changes were observed in the lung, tracheobronchial lymph nodes, and less commonly, the mesenteric lymph nodes. A mottled red and non-collapsing lung, the only gross finding observed in all three animals examined at DPE 1, was consistently observed in each animal and progressively increased in severity at each time point during the course of this study (100 %, 12/12). At DPE 3, 5 and 7, multiple and coalescing necrotizing and suppurative foci (grossly resembling abscesses), ranging from 0.5 to 1 cm diameter were randomly scattered on the right and left lung lobes of all animals. These slightly raised, necrotic foci contained yellowish-tan suppurative material, or less commonly were dry and friable, and rimmed by congestion and haemorrhage. The pulmonary lesions increased in overall number and size with the most severe measuring up to 3.0 cm in diameter (Fig. 2a) . A fibrinous pleuritis also developed adjacent to the subpleural necrotic foci. Mild tracheobronchial and mesenteric lymphadenopathy was present in all animals (100 %, 12/12) in varying degrees. The tracheobronchial lymph nodes in animals euthanized at DPE 3 (66 %, 2/3) and 5 (66 %, 2/3) were effaced by necrosuppurative material similar to lung lesions (Fig. 2b) . Enlargement of axillary and inguinal lymph nodes was inconsistently noted. No other clinically significant gross lesions were noted at necropsy.
Histological findings
Minimal multifocal areas of alveolar oedema was the only histologically significant change in the animals at DPE 1. Table 3 . PCR detection of B. pseudomallei-species-specific and Burkholderia-genus-specific organisms in tissues from rhesus macaques aerosol exposed to B. pseudomallei Data represent the number of positives out of a total of three unless noted otherwise (in parentheses). PCR was not conducted on control animal samples; however, it was conducted on preexposure samples from experimental animals and was never positive in these cases. P values represent comparison between the two PCR assays. Organism was never detected in uterus or testis. NA NA All animals at DPE 3, 5 and 7 had variable and chronologically progressive coalescing foci of necrosuppurative pneumonia. Within the most affected areas, the pulmonary architecture was effaced and replaced with extensive necrosis, haemorrhage, fibrin and oedema admixed with numerous degenerate and necrotic neutrophils, and fewer macrophages and lymphocytes (Fig. 2c) . Generally, a relatively sharp demarcation existed between the necrotic foci and minimally (or less) affected adjacent pulmonary tissue. Within the less affected areas, neutrophils, macrophages, haemorrhage, fibrin and oedema filled terminal bronchioles adjacent to the necrotic foci and extended into the alveolar spaces (Fig. 2d) . Occasionally, suppurative inflammation also ascended into small bronchioles and bronchi. By DPE 7, scattered fibroblasts were observed at the periphery of necrotic foci, a histological finding consistent with early abscess formation.
Fibrinous strands along the pleural surface of affected lung lobes (fibrinous pleuritis) were a common finding by DPE 5. The pleural lymphatic vessels were also markedly dilated and contained numerous degenerate neutrophils, few lymphocytes and plasma cells with moderate amounts of fibrin and cellular debris. At DPE 7, the pleura was markedly expanded by fibrin, previously described inflammation and loosely arranged fibroblasts in the subpleural connective tissue. This finding, most consistently observed adjacent to the larger, up to 3 cm diameter foci, was interpreted as an early attempt at fibrous capsule development, sequestration of the necrotizing and suppurative foci, and resultant abscess formation.
The most significant change in the lymphatic system was necrotizing lymphadenitis of the tracheobronchial and mesenteric lymph nodes by DPE 3 in five animals (42 %, 5/12). Necrotizing inguinal and axillary lymphadenitis was rarely observed and seen together in one animal only. Besides necrotizing lesions in all examined lymph nodes, this animal exhibited the most severe pulmonary lesions as well. Lymph nodes outside the pulmonary system had typical cortical Table 4 . Gross and histopathological findings in brief from rhesus macaques aerosol exposed to B. pseudomallei A score of 1-5 indicates the severity of inflammation present in the examined tissue: 0, no lesion; 1, minimal or ,5 % of tissue affected; 2, mild or 5 to 25 %; 3, moderate or 26 to 40 %; 4, marked or 41 to 60 %; 5, severe or .61 %. Non-exposed animals showed rare non-specific hepatitis only. (follicular) lymphocytic hyperplasia. This nodal hyperplasia was minimal to mild. Such changes in one or more lymph nodes can be seen in normal animals in response to normal physiological stimulation. However, some response to the challenging agent could not be completely ruled out.
Tissue examined
A mild necrotizing splenitis composed predominantly of neutrophils was observed in one animal. However, multiple animals had a substantial increase of mature neutrophils, filling red pulp sinuses in the absence of any histopathological lesions.
The tonsils often had minimal inflammation (50 %, 6/12) that was occasionally associated with mucosal cocci. It is difficult to determine the inciting source but the challenged agent is a possibility such that the cocci were present as an opportunistic infection.
There was minimal subacute inflammation in the hepatic sinusoids consisting of small foci of neutrophils with fewer lymphocytes and macrophages, as well as minimal damage or disruption to hepatic parenchyma in half of the infected animals. Random, albeit minimal, hepatic inflammation was occasionally seen in macaques without a history of hepatic disease and often considered a background lesion (Chamanza et al., 2010) .
Immunohistochemical and histochemical evaluation of B. pseudomallei
Two cases each from DPE 1 and 5 were selected to further identify B. pseudomallei using Giemsa, Lillie Twort Gram stain and immunohistochemistry. Two cases were chosen from DPE 1 on the basis of earliest detection possible, and DPE 5 based on differing levels of severity. Lung, liver, spleen, thymus and mediastinal lymph nodes were evaluated in this study. These tissues were selected because their lesions were determined to be a direct response to the challenged agent. The bacteria were only consistently detected in lung lesions in the animals. One animal had immunoreactivity in the mediastinal lymph node.
Rare positive immunoreactive inflammatory cells, predominantly alveolar macrophages, were identifiable in the alveoli on DPE 1 and not within alveolar septae (Fig. 2e) . This is the earliest and only immunoreactive cell noted in DPE 1 animals.
The abscesses containing suppurative material demonstrated strong positive immunoreactivity in the necrotic debris, and in the cytoplasm of neutrophils and macrophages. Immunoreactivity was also noted on the surface, but not in the cytoplasm, of normal pneumocytes immediately adjacent to the abscesses, indicating a lack of bacterial invasion. Bronchial and bronchiolar suppurative exudates and the adjacent cilia of the bronchiolar epithelium was immunopositive but not within the ciliated epithelial cells. Lung sections of control animals had no immunoreactivity.
Giemsa stain can be an alternative when immunohistochemistry is not available. Rare bacteria were identified in one of the DPE 1 animals. Low to moderate numbers of intracellular and extracellular rods were identified by Giemsa stain in the DPE 5 animals predominantly within neutrophils and macrophages and necrotic debris (Fig. 2f) .
Gram stains proved to be of little diagnostic value in this study. In the most severe lesions reviewed, Gram-negative bacteria were rarely seen and often difficult to discern from similar staining surrounding necrotic debris.
DISCUSSION
Melioidosis is a diagnostic challenge in human cases. This presents a particularly serious problem in regard to cases that may occur outside areas of endemic melioidosis (whereas within endemic areas cases are often diagnosed clinically and treated empirically) (Lipsitz et al., 2012) . Melioidosis can infect and cause disease in a wide array of mammals, and the pathogenesis and agent dissemination within animal species varies. For example, mice may develop pneumonia after intraperitoneal injection, indicating a preference for this organ by the bacteria. In mice, the lungs are the most consistently affected organ; however, lesions have also been reported in the spleen, liver, lymph nodes, kidney and joints. Goats are exceptional in that they may show wide-spread lesions including mastitis and neurological disease (Caswell & Williams, 2007) . Pneumonia is often a secondary process subsequent to B. pseudomallei-associated sepsis, but primary pneumonia may occur (Jeddeloh et al., 2003; van Schaik et al., 2008) . The data reported here reinforce prior studies that indicate that rhesus macaques develop a consistent and progressive pneumonia attributed to aerosol exposure to B. pseudomallei, similar to the disease history of human melioidosis. Therefore, the model appears to be appropriate for refining diagnostic algorithms and evaluating assays to diagnose melioidosis in humans. The study reported here represents a first step in this process.
The African Green monkey model has been described as a preferred model for medical countermeasure development because of the consistency of disease manifestations that may represent criteria by which to objectively assess and compare therapies or prophylaxis (Yeager et al., 2012) . However, melioidosis in humans is notably variable, as observed in the macaque model used here. Therefore, the rhesus macaque may be preferable for evaluating diagnostic assays or algorithms.
The dose used in this study was substantially (approx. 100-fold) lower than doses that have been shown to be lethal in rhesus macaques because the purpose of the study was to assess disease progression. However, there was some variation in estimated inhaled dose, which varies due to animal to animal and temporal variations in respiratory minute volume. This provided a fortuitous, albeit subjective, opportunity to further address the question of whether outcome is dose dependent. There was some indication of correlation between estimated inhaled dose and the severity of the lesions observed on different days; i.e. on any given DPE, the animal with the most severe or progressive lesions tended to be the animal with the highest estimated inhaled dose. This observation lends credence to the notion that outcome is dose dependent.
Overall, CBC and blood chemistry changes were variable, but consistent with bacterial infection with occasional liver involvement, possibly suggesting reticuloendothelial organ seeding, though not in any way indicative of a specific aetiology. These findings are consistent with the general lack of clinical pathology indicators of melioidosis in humans (Deris et al., 2010; Vidyalakshmi et al., 2007) .
In this study starting at DPE 3 and continuing until DPE 7, all animals developed significant pulmonary lesions (100 %, 9/9). Pulmonary changes progressed from alveolar oedema, to necrotizing bronchopneumonia and finally necrosuppurative bronchopneumonia with fibrinous pleuritis. Grossly and histologically, the pulmonary lesions formed distinct foci that increased in size and number over the 7 day period. There was a loss of pulmonary architecture with large amounts of necrosis, numerous degenerate neutrophils, necrotic leukocytes, fewer macrophages, lymphocytes admixed with fibrin, oedema and haemorrhage. Terminal bronchioles adjacent to the necrotizing foci often contained neutrophils with oedema and fibrin. These areas are likely the initial foci of changes due to the small particle size (1 mm) allowing the bacteria to seat deeply within the lungs. Beyond the inflammatory foci, airways were often normal. The cases from DPE 7 began to have scattered fibroblasts along the periphery of the distinct foci, consistent with early chronic suppurative abscess formation. It is unclear whether some cases might have resolved spontaneously; however, pathology clearly became progressively more severe over the 7 day course of the experiment, consistent with progressively worsening subjective clinical signs, haematology and blood chemistry indicators, and dissemination to other organs. This disease progression is consistent with human acute, aerosol exposure meliodosis.
The histopathological findings in the lungs of experimental animals were attributable to exposure to aerosolized B. pseudomallei. Among histological methods, immunohistochemistry appeared to be the most effective method to detect the bacteria within the first day during the subclinical phase and in the absence of gross lesions. B. pseudomallei stains well with Giemsa, and moderate numbers of bacteria were detectable in the necrotizing foci of inflammation in the lungs with this stain. There was roughly equivalent detection in the liver and mediastinal lymph nodes using Giemsa as compared to immunohistochemistry in DPE 5 animals. Gram stains were unrewarding in this study.
Surprisingly, PCR and culture results from lung tissue in this study were often discordant. This may have been due to early localization of bacteria, such that some areas of tissue did not contain bacteria. If it is accurate that many areas of lung tissue are free of organism while the organ as a whole is severely affected, then lung biopsy may not be a viable diagnostic option for antemortem diagnosis of human melioidosis. However, BAL may overcome the problem of possible unequal distribution of the organism in lung tissue and this study indicates that BAL is a good diagnostic option.
Importantly, lymphadenitis was common and obviously affected (enlarged) lymph nodes were universally culture and PCR positive. Thus, if the rhesus macaque is a model of human disease, then lymph node biopsy could be a viable approach to antemortem diagnosis of human melioidosis.
The gross pathology and histopathological assessments conducted in this study clearly show that B. pseudomallei disseminates to lymphatics in rhesus macaques. As a result, these may occasionally be suitable sources of samples for diagnostics. In the spleen, the increased number of neutrophils may have primarily reflected peripheral neutrophilia since there was no positive immunoreactivity detected in the spleens tested; however, PCR results were occasionally positive from splenic tissue. Hepatic inflammatory lesions indicated dissemination consistent with human disease and other NHP models; B. pseudomallei can spread to secondary sites like the liver, spleen and brain (Lazar et al., 2009; Nelson et al., 2011) .
B. pseudomallei was frequently recovered from non-invasive samples such as throat swabs and nasal swabs in this study, and this was occasionally confirmed by PCR. Thus, these non-invasive samples should be considered as a part of refined algorithms for diagnosis of melioidosis in humans (Wuthiekanun et al., 2001) . Consistent with clinical experience, blood culture was rarely positive and only low levels of bacteria were detected . Serum was occasionally PCR positive in samples taken at early time points, whereas the corresponding blood sample was not. This is consistent with observations from human diagnostics (Richardson et al., 2012) . This may reflect the presence of bacterial breakdown products in the blood at low concentrations. This should be a focus of future efforts to enhance diagnostics through sample concentration methods.
Consistent with clinical experience, in this study, culture again proved to be more consistently rewarding than PCR for many sample types. The correlation between culture and PCR results was imperfect in this study, perhaps due to variations in pathogen concentration within sampled tissues or perhaps due to insensitivity of the PCR assays for various samples, either due to extraction inefficiency for some tissues or inherent limitations of the PCR methods themselves. Generally, PCR positivity was more consistent when higher concentrations of organism were recovered by culture. However, PCR was most consistently positive from certain key samples, e.g. enlarged lymph nodes and BAL fluid. PCR has the benefit of more rapid results, whereas culture requires at least 18 h. Thus, PCR may be a useful complement to culture in diagnostic algorithms. In light of these findings, PCR of BAL or fine-needle aspirate of enlarged lymph nodes may be a rapid, definitive algorithm for melioidosis diagnosis. The well-characterized archive of samples generated in this study should serve as a useful tool for refinement of diagnostic assays and algorithms.
